Biological and clinical significance of cathepsin D in breast cancer metastasis.
about
Conformational switching in an aspartic proteinaseIn vivo imaging of tumors with protease-activated near-infrared fluorescent probesTowards a human repertoire of monocytic lysosomal proteins.Integration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and Prognosis.Two-dimensional electrophoretic comparison of metastatic and non-metastatic human breast tumors using in vitro cultured epithelial cells derived from the cancer tissues.Fast proteomic protocol for biomarker fingerprinting in cancerous cells.Heat shock cognate 70 protein secretion as a new growth arrest signal for cancer cellsDual-wavelength imaging of tumor progression by activatable and targeting near-infrared fluorescent probes in a bioluminescent breast cancer model.Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer.Imaging proteolysis by living human breast cancer cells.New insights into procathepsin D in pathological and physiological conditions.Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.The Apaf-1-binding protein Aven is cleaved by Cathepsin D to unleash its anti-apoptotic potentialExpression profile of cathepsins indicates the potential of cathepsins B and D as prognostic factors in breast cancer patients.Mannose 6-phosphate receptor targeting and its applications in human diseases.Cyr61 and YB-1 are novel interacting partners of uPAR and elevate the malignancy of triple-negative breast cancer.Loss of melanoregulin (MREG) enhances cathepsin-D secretion by the retinal pigment epitheliumThe function of cathepsins B, D, and X in atherosclerosis.Haematopoietic development and immunological function in the absence of cathepsin D.Benzophenone-1 and nonylphenol stimulated MCF-7 breast cancer growth by regulating cell cycle and metastasis-related genes via an estrogen receptor α-dependent pathway.A Time-Based and Intratumoral Proteomic Assessment of a Recurrent Glioblastoma Multiforme.The biochemistry of cancer dissemination.Tasiamide F, a potent inhibitor of cathepsins D and E from a marine cyanobacterium.Modulation of the estrogen-regulated proteins cathepsin D and pS2 by opioid agonists in hormone-sensitive breast cancer cell lines (MCF7 and T47D): evidence for an interaction between the two systems.Hybrid 2D/3D-quantitative structure-activity relationship and modeling studies perspectives of pepstatin A analogs as cathepsin D inhibitors.Interactions of a low molecular weight inhibitor from Streptomyces sp. MBR04 with human cathepsin D: implications in mechanism of inactivation.3,3'-Diindolylmethane Suppressed Cyprodinil-Induced Epithelial-Mesenchymal Transition and Metastatic-Related Behaviors of Human Endometrial Ishikawa Cells via an Estrogen Receptor-Dependent Pathway.Grassystatins D-F, Potent Aspartic Protease Inhibitors from Marine Cyanobacteria as Potential Antimetastatic Agents Targeting Invasive Breast Cancer.Disruption of endocytic trafficking protein Rab7 impairs invasiveness of cholangiocarcinoma cells.Cyanobacterial peptides as a prototype for the design of cathepsin D inhibitors.Fludioxonil induced the cancer growth and metastasis via altering epithelial-mesenchymal transition via an estrogen receptor-dependent pathway in cellular and xenografted breast cancer models.Nanohybridization of Low-Dimensional Nanomaterials: Synthesis, Classification, and ApplicationStructure-Activity Relationships of JMV4463, a Vectorized Cathepsin D Inhibitor with Antiproliferative Properties: The Unique Role of the AMPA-Based VectorAnalysis of Estrogen Receptor Polymorphism in Codon 325 by PCR-SSCP in Breast Cancer: Association With Lymph Node Metastasis
P2860
Q27765720-84C31A21-DE6E-47DE-B2DD-8E65506AB698Q28141852-E8C6165E-050F-4226-9A05-55FC95F84133Q30962551-2151325B-2A5A-4A36-AB12-CE1FF06BD6A0Q31111254-AF453230-9720-4DC0-B4CC-81B0E359D3BBQ33328683-4F0F3DA3-6097-4DA4-8D2D-AE75D6A0E361Q33798196-8B668074-76CC-46D8-BC39-FCEBD9D191ACQ33831321-71A25FE2-4600-4B95-8B75-2A04D803CD3EQ34163763-E5B4BC20-2ACD-4CFD-901E-EFFBAA38AD19Q34768332-4A7E32C4-39E1-44C7-9405-ED73C4EE6745Q34786084-13D01ADD-10EC-482C-88BC-244366A91040Q35915807-3DA5AEBA-3240-4194-954A-32C50D99DCE8Q36068428-000DD5BD-E3C5-47EF-BA24-7D77332DC98FQ36174027-D1FE278D-664C-495D-8D00-31CB38B64A82Q36502689-DBC58208-41BE-47C0-9063-E496B94DF508Q37066021-79E3C55F-F323-4350-A0D9-43A9418E2E67Q37536780-5995B351-0FEE-408E-B73C-2BC4A80136F1Q37551716-BDEDFBBC-F43F-44CA-ABA6-8D40BAC566DDQ37568511-81F4E926-C707-40D4-A588-FEF60BC5C250Q39251419-7AFDA12B-BA67-4569-AE69-A184F6F8D38CQ41105569-C6FC7F05-4C9C-413A-A846-0A3DFDE12AECQ41481825-05E5CF01-3398-4112-9D8B-D1064D4AD7AFQ41547351-0A82E4EE-926F-4DD2-A63E-DBCA88771ED3Q42407811-6AF8B586-0961-419A-A3E8-3002147F757DQ44350661-73D260C6-D21A-4E29-BE38-09F14B31B415Q46840528-984006BB-7C53-413E-9C12-9E5A42600E4AQ46849968-4AADC2AB-247C-424E-AE82-A94771CE7918Q47216897-E0587B28-B123-432E-8148-3C20D0D6262EQ47583201-4A6EC579-8E2A-4A76-8453-A223B6A45397Q47746007-F5D1F63C-E46C-4F22-8615-8B9D6EC793F3Q48323342-ABA8D54D-AEC9-45F1-A1DF-F312ECDC2948Q51563369-697C08F0-1E04-46BD-BBB3-60BE9E5F3DBAQ57370700-851F97C6-0730-46F2-BA99-A721BC765E1AQ58099642-7C0A1ABC-972A-4B2B-BD97-565D4F34100BQ58835547-D957F0ED-B466-4284-83FD-AC29863470FE
P2860
Biological and clinical significance of cathepsin D in breast cancer metastasis.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Biological and clinical significance of cathepsin D in breast cancer metastasis.
@en
type
label
Biological and clinical significance of cathepsin D in breast cancer metastasis.
@en
prefLabel
Biological and clinical significance of cathepsin D in breast cancer metastasis.
@en
P2093
P356
P1433
P1476
Biological and clinical significance of cathepsin D in breast cancer metastasis.
@en
P2093
Brouillet JP
Rochefort H
P304
P356
10.1002/STEM.140642
P577
1996-11-01T00:00:00Z